Reversal of High Fat Diet-Induced Obesity, Systemic Inflammation, and Astrogliosis by the NLRP3 Inflammasome Inhibitors NT-0249 and NT-0796
Peter Thornton(Community Health Systems - Lutheran Hospital), Alan P. Watt(Chelmsford and Essex Hospital), Zsofia Digby, Pamela J. Smolak(University of North Carolina at Chapel Hill), David Harrison(University of Notre Dame), Valérie Reader(Chelmsford and Essex Hospital), Nick Clarke, Nicola Lindsay
Cited by 51
Related Papers
Discovery of Clinical Candidate NT-0796, a Brain-Penetrant and Highly Potent NLRP3 Inflammasome Inhibitor for Neuroinflammatory Disorders
|Journal of Medicinal Chemistry|2023|62
Identification of a novel GPR81-selective agonist that suppresses lipolysis in mice without cutaneous flushing
|European Journal of Pharmacology|2014|54
Myocardial Hypertrophy Resulting from Low Dosage Isoproterenol Administration in Rats
|Experimental Biology and Medicine|1971|49
Engineering transglycosidase activity into a GH51 α-l-arabinofuranosidase
|New Biotechnology|2013|35
1,2,4-Triazolo-[1,5-<i>a</i>]pyridine HIF Prolylhydroxylase Domain-1 (PHD-1) Inhibitors With a Novel Monodentate Binding Interaction
|Journal of Medicinal Chemistry|2017|34